Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2013
06/18/2013CA2592437C Lyophilization of virosomes
06/18/2013CA2571405C Composition and method for treating hemorrhoids and/or anorectal disorders
06/18/2013CA2567722C A dried and agglomerated hyaluronic acid product
06/18/2013CA2563489C Topical methadone compositions and methods for using the same
06/18/2013CA2546637C Colonic purgative composition with soluble binding agent
06/18/2013CA2534895C Hemostatic compositions containing sterile thrombin
06/18/2013CA2531640C Intravaginal drug delivery devices
06/18/2013CA2520312C Matrix compositions for controlled delivery of drug substances
06/18/2013CA2483656C Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine
06/18/2013CA2483102C Treatment and prevention of pulmonary conditions
06/18/2013CA2475923C Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
06/18/2013CA2463459C Novel use of pulmonary surfactant
06/18/2013CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis
06/15/2013CA2798913A1 Organogel compositions comprising alkylated aromatic acids
06/13/2013WO2013086526A1 Liposomal drug encapsulation
06/13/2013WO2013086518A1 Skin care formulation
06/13/2013WO2013086449A1 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
06/13/2013WO2013086438A1 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
06/13/2013WO2013086382A1 Method for bowel preparation
06/13/2013WO2013086373A1 Lipids for the delivery of active agents
06/13/2013WO2013086313A1 Nanoformulation of vitamin d derivatives and/or vitamin d metabolites
06/13/2013WO2013086292A1 Glucagon formulations
06/13/2013WO2013086196A1 Topical formulation for administering a compound
06/13/2013WO2013086015A1 Medical organogel processes and compositions
06/13/2013WO2013085904A1 Oral spray formulations and methods for administration of sildenafil
06/13/2013WO2013085814A2 Monomer systems with dispersed silicone-based engineered particles
06/13/2013WO2013085784A1 Compositions and methods for topical nitric oxide generation
06/13/2013WO2013085769A1 Cellulosic gel composition with improved viscosity stability
06/13/2013WO2013085502A1 Composition and method for arresting blood flow and for forming a persistent antimicrobial barrier
06/13/2013WO2013085276A1 Film for oral administration containing mirodenafil or pharmaceutically acceptable salt thereof
06/13/2013WO2013085224A1 Bitter taste masked oral thin film formulation of sildenafil citrate
06/13/2013WO2013084995A1 Adhesive patch
06/13/2013WO2013084922A1 Bicarbonate dialysis agent
06/13/2013WO2013084244A1 Stable lactase drops
06/13/2013WO2013084207A1 Formulations for micelle formation comprising a protein and methods preparation thereof
06/13/2013WO2013084194A1 Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents
06/13/2013WO2013084191A1 Orodispersible sildenafil tablet and preparation method thereof
06/13/2013WO2013084090A1 Oral liquid concentrate comprising brompheniramine, pseudoephedrine and dextromethorphan
06/13/2013WO2013084059A1 Pharmaceutical dosage forms comprising poly (epsilon- caprolactone) and polyethylene oxide
06/13/2013WO2013083965A1 Patch containing non-steroidal anti-inflammatory drug
06/13/2013WO2013083910A2 Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants
06/13/2013WO2013083776A1 Dry powder formulation of azole derivative for inhalation
06/13/2013WO2013083710A1 Tablet capable of combatting misuse by injection
06/13/2013WO2013083605A1 Triptorelin pharmaceutical composition
06/13/2013WO2013083569A1 Nasal formulation
06/13/2013WO2013083558A1 Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
06/13/2013WO2013083460A1 Robust controlled-release formulations
06/13/2013WO2013083459A1 Robust controlled-release peptide formulations
06/13/2013WO2013083431A1 Skin anti-ageing composition
06/13/2013WO2013083041A1 Microspheres for controlled- or sustained-release delivery of therapeutics
06/13/2013WO2013082875A1 Arsenic compound solution and albumin nanoparticle and lyophilized preparation entrapping arsenic compound prepared using same
06/13/2013WO2013082839A1 Drug-loaded liposome for overcoming tumor drug resistance, method for preparing same, and application thereof
06/13/2013WO2013082706A1 Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing
06/13/2013WO2013058511A3 Method for preparing high-purity montelukast sodium salt
06/13/2013WO2013057570A3 Acrylic polymer formulations
06/13/2013WO2013056132A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
06/13/2013WO2013055058A9 Antibody-binding peptide-ferritin fusion protein and uses thereof
06/13/2013WO2013054178A8 Extended release pharmaceutical compositions containing carmabazepine
06/13/2013WO2013050156A8 Process line for the production of freeze-dried particles
06/13/2013WO2013048235A3 A medicinal herbal ointment
06/13/2013WO2013038268A8 Tamper resistant immediate release formulations
06/13/2013WO2013033304A3 Capsule having broad color spectrum
06/13/2013WO2013032248A3 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient
06/13/2013WO2013016544A4 Templated islet cells and small islet cell clusters for diabetes treatment
06/13/2013WO2013006809A3 Aerosolizing particles
06/13/2013WO2012170419A3 Oil dispersion of sulfoximines for the control of insects
06/13/2013WO2012125987A9 Delivery system
06/13/2013US20130150410 Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders
06/13/2013US20130150348 Composition
06/13/2013US20130150291 Therapeutic agents comprising insulin amino acid sequences
06/13/2013US20130149539 Tuned multifunctional magnetic nanoparticles for biomedicine
06/13/2013US20130149385 Nanoformulation of vitamin d derivatives and/or vitamin d metabolites
06/13/2013US20130149381 Absorption method for entrapment of drugs in polymeric nanoparticles
06/13/2013US20130149379 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
06/13/2013US20130149377 Custom-pill compounding system with filler-free capability
06/13/2013US20130149374 Asymmetric Liposomes for the Highly Efficient Encapsulation of Nucleic Acids and Hydrophilic Anionic Compounds, and Method for Preparing Same
06/13/2013US20130149362 Treatment product and method
06/13/2013US20130149361 Encapsulated pink tourmaline for skin
06/13/2013US20130149359 Effervescent Mouthwash
06/13/2013US20130149357 Porous Degradable Polyelectrolyte Microspheres as Vaccine Vector
06/13/2013US20130149354 Coated elastomeric article and method for making a coated elastomeric article
06/13/2013US20130149353 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/13/2013US20130149352 Apparatus and method for the treatment of abnormal uterine bleeding
06/13/2013US20130149351 Polymer scaffolds and their use in the treatment of vision loss
06/13/2013US20130149350 Pharmacokinetics of S-Adenosylmethionine Formulations
06/13/2013US20130149345 Respirably dry powder comprising calcium lactate, sodium chloride and leucine
06/13/2013US20130149344 Pleasure Enhancing Condom
06/13/2013US20130149343 Hemostatic Bioabsorbable Device with Polyethylene Glycol Binder
06/13/2013US20130149254 Chewable pouch for flavored product delivery
06/13/2013US20130146502 3,5,3'-Triiodothyronine Sulfate As Thyromimetic Agent And Pharmaceutical Formulations Thereof
06/13/2013US20130146496 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
06/13/2013DE102012024025A1 Flavored chewing tablet comprises two powders having sensory distinguishable grain sizes, where one of the powders is aromatized as flavor carrier and a coarse-grained powder is embedded into a matrix of the fine-grained powder
06/13/2013CA2858868A1 Pharmaceutical dosage forms comprising poly (epsilon-caprolactone) and polyethylene oxide
06/13/2013CA2858741A1 Liposomes and corresponding production method
06/13/2013CA2858574A1 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
06/13/2013CA2858478A1 Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing
06/13/2013CA2858364A1 Oral spray formulations and methods for administration of sildenafil
06/13/2013CA2858331A1 Tablet capable of combatting misuse by injection
06/13/2013CA2858312A1 Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants
06/13/2013CA2858234A1 Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 2991